Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
News Outlets Examine Public, Private Funding For Ebola, Other Disease Vaccine Research

News outlets discuss funding for research on vaccines for Ebola and other neglected diseases. Bloomberg TV: Neglected Diseases: Who Should Pay for Vaccine Research? “Christopher Egerton-Warburton, fund manager at Global Health Investment Fund, and Martin McKee of London School of Hygiene and Tropical Diseases discuss the lack of preparation and research…

Devex Examines USAID’s Incorporation Of PPPs Into Foreign Assistance

Devex: USAID PPPs by the numbers “…The world’s biggest bilateral donor, the U.S. Agency for the International Development was one of the first development agencies to embed PPPs into its foreign assistance model — a move that prompted praise from the Organization for Economic Cooperation and Development. … Since the…

Public, Private Entities Continue Efforts To Develop Ebola Vaccines, Therapies

Media outlets report on various aspects of efforts to develop a vaccine for Ebola and produce more doses of experimental drugs to treat the disease. ABC News: Will There Be an Ebola Vaccine Soon? (Besser, 10/17). Agence France-Presse: Experimental Ebola vaccine expected in Geneva Tuesday: hospital (10/19). Agence France-Presse: Ebola…

China Sends Experimental Ebola Drug To Africa For Clinical Trials

News outlets report that China has sent an experimental drug developed by its military to Africa for clinical trials. Financial Times: China sends thousands of doses of anti-Ebola drug to Africa “China has sent thousands of doses of an experimental anti-Ebola drug developed by the Chinese military to Africa. The…

Opinion Pieces Recognize Global Handwashing Day

The following opinion pieces discuss Global Handwashing Day, recognized on October 15. Huffington Post: Global Handwashing Day in the Time of Ebola Jeffrey Sachs, director of the Earth Institute at Columbia University, and Myriam Sidibe, global social mission director at Unilever-Lifebuoy “…On this Global Handwashing Day, let’s commit ourselves to…

Zuckerberg Donates $25M To U.S. Ebola Efforts

News outlets report on Facebook co-founder and CEO Mark Zuckerberg’s donation of $25 million to the U.S. Centers for Disease Control and Prevention Foundation’s Ebola fund. The Hill: Zuckerberg gives $25M to CDC Ebola fund (Hattem, 10/14). PBS NewsHour: Mark Zuckerberg to give $25M to fight Ebola (Morris, 10/14). USA TODAY:…

Investigational Rotavirus Vaccine In Late-Stage Clinical Trials

Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials “French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14).

International Entities Helping To Prevent HIV Drug Shortage In India

Reuters: Pharmaceutical companies, WHO help India in HIV/AIDS drug crisis “Indian companies and global health groups are stepping up efforts to provide a critical medicine for the country’s free HIV/AIDS drugs program after more than 150,000 patients risked going without their dosages this month. Delayed tender approvals and poor coordination…

Tackling TB In India Requires Both Public, Private Sector Engagement

The Hindu: Fighting India’s silent epidemic Soumya Swaminathan, director of the National Institute for Research in Tuberculosis in Chennai, and Chapal Mehra, New Delhi-based writer “Over 60 percent of all Indians seek health care in the private sector, according to India’s last National Family Health Survey. … Even though parallel…

Search Is On For New Slate Of Malaria ‘Wonder Drugs’

Devex: Complete cure Martin Edlund, CEO of Malaria No More “…With hundreds of millions of people infected with malaria around the globe every year, effective treatment may be the difference between ending the disease and humanitarian disaster. … Our current front-line treatments for malaria, called artemisinin-based combination therapies, underscore the…